Navigation Links
Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
Date:1/6/2009

SAN DIEGO, Jan. 6 /PRNewswire/ -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate Accounts.

"Andrew brings the right mix of energy and expertise to Accumetrics. His experience will help us reach the next level in terms of our market penetration," says Timothy I. Still, President and CEO at Accumetrics. "His knowledge of the medical diagnostics industry and his relationships with distributors make him a key component of our growth strategy in 2009 and beyond."

Prior to joining Accumetrics, Mr. Chisholm served as Vice President of Sales and Corporate Accounts at Hemosense, a medical diagnostics company located in San Jose, California which was acquired by Inverness Medical in November 2007. Prior to that, Mr. Chisholm managed sales and marketing activities with increasing responsibilities at Bayer Healthcare, Henry Schein, Johnson & Johnson and the Eastman Kodak Company.

About Accumetrics (www.accumetrics.com):

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

    CONTACT:  Jules Abraham
              Lippert Heilshorn & Associates
              212-838-3777
              jabraham@lhai.com

              Timothy I. Still
              Accumetrics
              press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Algeta Appoints Andrew Kay as President and Chief Executive Officer
2. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
3. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
4. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
5. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. Timothy I. Still Appointed CEO at Accumetrics
8. Robert Cantu Appointed Vice President of Pierpoint International
9. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
10. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
11. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Executive ... 2017 in its continued commitment to the advancement of the clinical trials segment. ... issues related to clinical trial planning and management. , As executive talent ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has ... Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables ... for further growth in 2017. Extractable & Leachable evaluations have become increasingly more ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... paralysis, today announced that it has submitted a 510(k) to the FDA, requesting ... utilize MYOLYN’s patent-pending functional electrical stimulation (FES) technology. , The submission marks ...
(Date:1/18/2017)... PA (PRWEB) , ... January 18, 2017 , ... ... operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency ... engaging panel discussions to examine vital clinical research issues such as trial performance ...
Breaking Biology Technology:
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
Breaking Biology News(10 mins):